InspireMD, Inc. (NYSE: NSPR) announced the online publication of positive clinical data in a new independent study performed by Prof ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE